Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Discovery of 4-arylamido 3-methyl isoxazole derivatives as novel FMS kinase inhibitors

Authors
Im, DaseulJung, KyungjinYang, SongyiAman, WagarHah, Jung-Mi
Issue Date
Sep-2015
Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
Keywords
4-arylamido 3-methyl isoxazoles; Antiproliferative activity; Hematopoietic cell line; Kinase inhibitor; Kinase selectivity
Citation
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v.102, pp.600 - 610
Indexed
SCIE
SCOPUS
Journal Title
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume
102
Start Page
600
End Page
610
URI
https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/17058
DOI
10.1016/j.ejmech.2015.08.031
ISSN
0223-5234
Abstract
A series of 4-arylamido 3-methyl isoxazoles were synthesized and evaluated for their antiproliferative activities against the A375P melanoma and U937 hematopoietic cell lines. Most compounds showed selective antiproliferative activity toward the U937 cell line and the activities were better than that of sorafenib, the reference standard. Derivatives were made as amide 5a-b, 6a-o and urea 7a-n, 8a-g with hydrophobic moieties, and one of the most potent inhibitor 6a, 5-methyl-N-(2-methyl-5-(3-(4-methylpiperazin-l-yl)-5-(trifluoromethyl)benzamido)pherwl)isoxazole-4-carboxamide was found to be very potent inhibitor of FMS kinase (GI(50) = 0.016 mu M, IC50 = 9.95 nM) with excellent selectivity profiles and is a promising candidate for further development in therapeutics for cancer. (C) 2015 Elsevier Masson SAS. All rights reserved.
Files in This Item
Go to Link
Appears in
Collections
COLLEGE OF PHARMACY > DEPARTMENT OF PHARMACY > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Hah, Jung Mi photo

Hah, Jung Mi
COLLEGE OF PHARMACY (DEPARTMENT OF PHARMACY)
Read more

Altmetrics

Total Views & Downloads

BROWSE